Nubexa CJC-1295 No DAC + Ipamorelin Research Blend

This is a pre-mixed research blend of CJC-1295 No DAC (5mg) and Ipamorelin (5mg) — one of the most extensively studied combinations in GH-secretagogue research.

— Mechanism Of Action

The combination engages two distinct pituitary pathways simultaneously: CJC-1295 binds GHRH receptors (cAMP pathway), while Ipamorelin binds GHS-R1a (calcium pathway). The dual stimulation is studied for synergistic GH release.

— Research Applications

Used in: GHRH/GHS combination research, comparative dual-pathway GH studies, pituitary research.

— Product Specifications

Compound	CJC-1295 No DAC + Ipamorelin Research Blend
Available Strengths	10mg
Purity	≥99% (verified by HPLC)
Form	Lyophilized powder
Storage	-20°C, protected from light
Reconstitution	Bacteriostatic water (sold separately)
Shelf Life	36 months (lyophilized, properly stored)
Certificate of Analysis	Available upon request — contact us

— What’s Included

Sealed lyophilized vial(s) of CJC-1295 No DAC + Ipamorelin Research Blend
Lot number and product information
Discreet, temperature-controlled packaging
Tracked international shipping

⚠ FOR RESEARCH USE ONLY
This product is sold strictly for laboratory research purposes. Must be 21 years or older to purchase. By placing this order you confirm that you are a qualified researcher or representative of a research organization purchasing this material exclusively for in vitro research applications.

Nubexa CJC-1295 No DAC + Ipamorelin Research Blend

— Mechanism Of Action

— Research Applications

— Product Specifications

— What’s Included

Reconstitution

Storage

Disclaimer